SCHEMBL9112837

SCHEMBL9112837

[CH2]C1CNCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL358405 0.71
SCHEMBL874360 0.71
SCHEMBL9112845 0.62
SCHEMBL8226017 0.62
SCHEMBL12661540 0.59
SCHEMBL969352 0.58
SCHEMBL1829141 0.57
SCHEMBL14506007 0.57
SCHEMBL12075738 0.57
SCHEMBL7999478 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101237866-A Use of thiazole derivatives and analogues in the treatment of cancer BETAGENON AB (SE) 2008-08-06 CN disclosed
CN-1162427-C Amine derivatives compounds ������������ʽ���� 2004-08-18 CN disclosed
CN-1226833-A Therapeutic agent for autoimmune disease SANKYO CO (JP) 1999-08-25 CN disclosed
CN-1224611-A Method and composition for treatment and prevention of hyperuricemia SANKYO CO (JP) 1999-08-04 CN disclosed
CN-1114834-A antidiabetic agent OTSUKA PHARMA CO LTD (JP) 1996-01-10 CN disclosed
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed
US-4083989-A MORPHOGENETIC HORMONAL MIMETIC ACTIVITY CHEVRON RESEARCH COMPANY (US) 1978-04-11 US disclosed
US-3988471-A Insect control employing certain benzoates CHEVRON RESEARCH COMPANY (US) 1976-10-26 US disclosed